Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessing the Performance of a Novel Stool-Based Microbiome Test That Predicts Response to First Line Immune Checkpoint Inhibitors in Multiple Cancer Types.
Robinson I, Hochmair MJ, Schmidinger M, Absenger G, Pichler M, Nguyen VA, Richtig E, Rainer BM, Ay L, Jansen C, Pacífico C, Knabl A, Sladek B, Gasche N, Valipour A. Robinson I, et al. Among authors: schmidinger m. Cancers (Basel). 2023 Jun 21;15(13):3268. doi: 10.3390/cancers15133268. Cancers (Basel). 2023. PMID: 37444378 Free PMC article.
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.
Motzer RJ, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Alekseev B, Rha SY, Merchan J, Goh JC, Lalani AA, De Giorgi U, Melichar B, Hong SH, Gurney H, Méndez-Vidal MJ, Kopyltsov E, Tjulandin S, Gordoa TA, Kozlov V, Alyasova A, Winquist E, Maroto P, Kim M, Peer A, Procopio G, Takagi T, Wong S, Bedke J, Schmidinger M, Rodriguez-Lopez K, Burgents J, He C, Okpara CE, McKenzie J, Choueiri TK; CLEAR Trial Investigators. Motzer RJ, et al. Among authors: schmidinger m. J Clin Oncol. 2024 Apr 10;42(11):1222-1228. doi: 10.1200/JCO.23.01569. Epub 2024 Jan 16. J Clin Oncol. 2024. PMID: 38227898 Free PMC article. Clinical Trial.
The European Society for Medical Oncology Magnitude of Clinical Benefit Scale in daily practice: a single institution, real-life experience at the Medical University of Vienna.
Kiesewetter B, Raderer M, Steger GG, Bartsch R, Pirker R, Zöchbauer-Müller S, Prager G, Krainer M, Preusser M, Schmidinger M, Zielinski CC. Kiesewetter B, et al. Among authors: schmidinger m. ESMO Open. 2016 Jul 4;1(4):e000066. doi: 10.1136/esmoopen-2016-000066. eCollection 2016. ESMO Open. 2016. PMID: 27843624 Free PMC article.
Sunitinib Rechallenge in Patients With Metastatic Renal Cell Carcinoma.
Nachbargauer S, Bruchbacher A, Fajkovic H, Remzi M, Schmidinger M. Nachbargauer S, et al. Among authors: schmidinger m. Clin Genitourin Cancer. 2020 Jun;18(3):e277-e283. doi: 10.1016/j.clgc.2019.11.006. Epub 2019 Dec 4. Clin Genitourin Cancer. 2020. PMID: 31902715 Clinical Trial.
PD1/PD-L1 therapy in metastatic renal cell carcinoma.
Bruchbacher A, Lemberger U, Hassler MR, Fajkovic H, Schmidinger M. Bruchbacher A, et al. Among authors: schmidinger m. Curr Opin Urol. 2020 Jul;30(4):534-541. doi: 10.1097/MOU.0000000000000788. Curr Opin Urol. 2020. PMID: 32453005 Review.
Thirteen-year analyses of medical oncology outpatient day clinic data: a changing field.
Marhold M, Topakian T, Agis H, Bartsch R, Berghoff AS, Brodowicz T, Fuereder T, Ilhan-Mutlu A, Kiesewetter B, Krainer M, Locker GJ, Marosi C, Prager G, Schmidinger M, Thallinger C, Zöchbauer-Müller S, Raderer M, Preusser M, Lamm W. Marhold M, et al. Among authors: schmidinger m. ESMO Open. 2020 Oct;5(5):e000880. doi: 10.1136/esmoopen-2020-000880. ESMO Open. 2020. PMID: 33051192 Free PMC article.
160 results